A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness
J.M. Langley, F. Aoki, B.J. Ward, A. McGeer, J.B. Angel, G. Stiver, I. Gorfinkel, D. Shu, L. White, B. Lasko, P. Dzongowski, K. Papp, M. Alexander, G. Boivin, L. FriesVolume:
29
Year:
2011
Language:
english
DOI:
10.1016/j.vaccine.2010.12.100
File:
PDF, 417 KB
english, 2011